Chemed (CHE) Accumulated Expenses (2009 - 2026)

Chemed (CHE) has reported Accumulated Expenses for 18 consecutive years, with $62.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Accumulated Expenses rose 4.75% year-over-year to $62.8 million; the TTM figure through Mar 2026 stood at $62.8 million (up 4.75% YoY), while the FY2025 annual figure was $58.3 million, down 36.65% from the prior year.
• Accumulated Expenses came in at $62.8 million for Q1 2026 at Chemed, up from $58.3 million in the prior quarter.
• The five-year high for Accumulated Expenses was $92.1 million in Q4 2024, with the low at $49.8 million in Q1 2024.
• Average Accumulated Expenses over 5 years is $69.5 million, with a median of $68.3 million recorded in 2022.
• The largest YoY upside for Accumulated Expenses was 20.29% in 2025 against a maximum downside of 36.65% in 2025.
• Year by year, Accumulated Expenses stood at $87.4 million in 2022, then grew by 1.18% to $88.4 million in 2023, then rose by 4.18% to $92.1 million in 2024, then sank by 36.65% to $58.3 million in 2025, then grew by 7.58% to $62.8 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $62.8 million, $58.3 million, and $79.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.